Cardiff Oncology, Inc. has executed an amendment to its license agreement with Nerviano Medical Sciences, effectively resolving ongoing legal disputes. This is a significant development as it formalizes the mutual settlement and clears previous uncertainties regarding the parties' commercial and IP rights under their collaboration.